Adverum Biotechnologies, Inc. (ADVM)
NASDAQ: ADVM · Real-Time Price · USD
7.32
+0.27 (3.83%)
Aug 23, 2024, 4:00 PM EDT - Market closed
Adverum Biotechnologies Market Cap
Adverum Biotechnologies has a market cap or net worth of $152.26 million as of August 23, 2024. Its market cap has decreased by -17.61% in one year.
Market Cap
152.26M
Enterprise Value
52.32M
1-Year Change
-17.61%
Ranking
Category
Stock Price
$7.32
Market Cap Chart
Since July 31, 2014, Adverum Biotechnologies's market cap has decreased from $581.50M to $152.26M, a decrease of -73.82%. That is a compound annual growth rate of -12.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 23, 2024 | 152.30M | 100.13% |
| Dec 29, 2023 | 76.10M | 31.66% |
| Dec 30, 2022 | 57.80M | -66.53% |
| Dec 31, 2021 | 172.70M | -83.66% |
| Dec 31, 2020 | 1.06B | 42.01% |
| Dec 31, 2019 | 744.10M | 275.81% |
| Dec 31, 2018 | 198.00M | 25.63% |
| Dec 29, 2017 | 157.60M | 30.25% |
| Dec 30, 2016 | 121.00M | -50.65% |
| Dec 31, 2015 | 245.20M | -79.79% |
| Dec 31, 2014 | 1.21B | 108.67% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Fennec Pharmaceuticals | 154.04M |
| Amylyx Pharmaceuticals | 153.87M |
| Achieve Life Sciences | 152.48M |
| Alpha Tau Medical | 152.43M |
| Century Therapeutics | 151.64M |
| Capricor Therapeutics | 149.03M |
| Immunic | 146.83M |
| Kodiak Sciences | 146.44M |